Résumé
BACKGROUND: We evaluated the efficacy and toxicity of docetaxel plus cisplatin combination as first-line chemotherapy for advanced gastric cancer. METHODS: Patients with metastatic or recurrent gastric adenocarcinoma, performance score Sujets)
Humains
, Adénocarcinome
, Cisplatine
, Traitement médicamenteux
, Association de médicaments
, Neutropénie fébrile
, Neutropénie
, Tumeurs de l'estomac